Sarepta Therapeutics (NASDAQ:SRPT) Price Target Increased to $213.00 by Analysts at Bank of America
Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its target price upped by Bank of America from $166.00 to $213.00 in a research report released on Friday morning, Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. SRPT has been the topic of several other reports. Needham & Company LLC reaffirmed […]
More Stories
Stryker Co. (NYSE:SYK) Plans $0.80 Quarterly Dividend
Stryker Co. (NYSE:SYK – Get Free Report) announced a quarterly dividend on Wednesday, August 7th, Wall Street Journal reports. Stockholders...
Arteris, Inc. (NASDAQ:AIP) Short Interest Down 19.8% in September
Arteris, Inc. (NASDAQ:AIP – Get Free Report) was the recipient of a significant decline in short interest in the month...
Agrify Co. (NASDAQ:AGFY) Short Interest Down 28.8% in September
Agrify Co. (NASDAQ:AGFY – Get Free Report) was the recipient of a large drop in short interest in the month...
BlackBerry (NYSE:BB) Releases FY25 Earnings Guidance
BlackBerry (NYSE:BB – Get Free Report) updated its FY25 earnings guidance on Thursday. The company provided earnings per share (EPS)...
Bloom Energy Co. (NYSE:BE) Receives Consensus Rating of “Hold” from Brokerages
Shares of Bloom Energy Co. (NYSE:BE – Get Free Report) have earned an average recommendation of “Hold” from the twenty...
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 27.7% in September
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) was the recipient of a significant increase in short interest in the...